Month: January 2020

Details Emerge in KU Hospital Misdiagnosis by Pathology Chair

AFTER A PATIENT FILED A LAWSUIT against a pathologist at the University of Kansas Hospital for fraud and negligence in a case stemming from a misdiagnosis of cancer in 2015, details about a settlement in the case were sealed. Now, some details have come out. Last month, NPR station KCUR in Kansas City reported that …

Details Emerge in KU Hospital Misdiagnosis by Pathology Chair Read More »

Converting Paper Requisitions to Digital Cut Lab’s Costs

CEO SUMMARY: Health Network Laboratories cut costs and shortened lab test turnaround time by converting paper requisitions to digital data. It did so by scanning paper requisitions and having a vendor do the required data entry. This helped the lab reduce errors in its patient data. Using this paper-to-digital system allowed the lab to adopt …

Converting Paper Requisitions to Digital Cut Lab’s Costs Read More »

Veritas Genetics to Close Its Testing Operations in U.S.

MAYBE CHARGING CONSUMERS THE LOW PRICE of $599 for a whole human genome sequence is not a winning financial strategy. That’s one possible reason why closely-watched Veritas Genetics of Cambridge, Mass., will stop operations in the United States. It was in July that Veritas announced it was cutting its already-low price to sequence a genome …

Veritas Genetics to Close Its Testing Operations in U.S. Read More »

Anti-Trust Regulators Opposed Illumina, Pacific Bioscience Deal

IN TWO COUNTRIES, regulators concerned about a possible monopoly of technologies and instruments used in human gene sequencing apparently were a major reason why the $1.2 billion acquisition of Pacific Biosciences by Illumina Corporation will not happen. The two companies announced the termination of the transaction just weeks after the Federal Trade Commission (FTC) ruled the …

Anti-Trust Regulators Opposed Illumina, Pacific Bioscience Deal Read More »

How Northwell’s Lab Team Demonstrated Value Over 10 Years

CEO SUMMARY: Among hospital administrators, the popular wisdom is that their clinical lab is a cost center. This thinking leads them to consider drastic cost-management strategies that include partnering with commercial labs to manage in-hospital lab testing and the outright sale of lab outreach programs. On the other side of this debate, innovative health system …

How Northwell’s Lab Team Demonstrated Value Over 10 Years Read More »

Pathology Groups Should Plan to Use Digital Pathology

WHEN AN ANATOMIC PATHOLOGY GROUP CONSIDERS IMPLEMENTING digital pathology and whole-slide imaging (WSI) for primary diagnosis, it must identify and understand a range of challenges and opportunities. “Every pathology group should start by considering how it will use the related technologies of a digital pathology (DP) system and whole-slide imaging,” said Liron Pantanowitz, MD, Vice …

Pathology Groups Should Plan to Use Digital Pathology Read More »

Labs May Be Excluded from Revised Stark, AKS Rules

CEO SUMMARY: When CMS and the OIG issued proposed rules last fall to make it easier for providers to participate in value-based and coordinated care arrangements, they considered excluding clinical labs, pharma companies, and DME firms because of concerns that the proposed rules could promote lab test fraud. Now, labs will have to wait for …

Labs May Be Excluded from Revised Stark, AKS Rules Read More »

Labs May Be Excluded from Revised Stark Law, AKS Rules

This is an excerpt of a 1,460-word article in the Jan. 6, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Here are early insights about a federal compliance reform that has not gotten much attention among clinical laboratory and anatomic pathology managers. …

Labs May Be Excluded from Revised Stark Law, AKS Rules Read More »

In LabCorp Case, Judge Upholds Some Claim

CEO SUMMARY: In a federal lawsuit against Laboratory Corporation of America, plaintiffs who were uninsured or underinsured charged the lab company with engaging in “business practices that trick and harass customers into paying excessive prices.” Plaintiffs made this and other claims in court documents alleging that LabCorp overcharged them by two to five and as …

In LabCorp Case, Judge Upholds Some Claim Read More »

Labs Face New Challenges in New Year, New Decade

TYPICALLY, PEOPLE CELEBRATE THE ARRIVAL OF A NEW YEAR and a new decade with optimism. That should be just as true for clinical lab managers and pathologists. After all, medical laboratory testing is fundamental to how physicians diagnose disease, select the most appropriate therapies, and monitor the progress of their patients. Yet events of recent …

Labs Face New Challenges in New Year, New Decade Read More »